IN BRIEF: Fresenius Kabi To Expand Austrian Facilities

Fresenius SE & Co KGaA - German healthcare firm - Says Fresenius Kabi is further expanding its ...

Alliance News 9 February, 2021 | 4:00PM
Email Form Facebook Twitter LinkedIn RSS

Fresenius SE & Co KGaA - German healthcare firm - Says Fresenius Kabi is further expanding its Austrian facilities, and will invest more than EUR60 million through 2023 to expand capacity and upgrade infrastructure at its production plant in Graz and packaging center in nearby Werndorf.

Fresenius Kabi, a subsidiary of Fresenius SE & Co, produces liquid pharmaceuticals and clinical nutrition products for the Austrian and international markets in Graz.

Current stock price: EUR34.96

Year-to-date change: down 7.6%

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Fresenius SE & Co KGaA 26.65 EUR 0.53

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures